These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 3627361

  • 1. Characterization of [3H]cholecystokinin octapeptide binding to mouse brain synaptosomes: effects of neuroleptics.
    Hama Y, Ebadi M.
    Neurochem Res; 1987 Aug; 12(8):729-37. PubMed ID: 3627361
    [Abstract] [Full Text] [Related]

  • 2. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
    Durieux C, Ruiz-Gayo M, Corringer PJ, Bergeron F, Ducos B, Roques BP.
    Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
    [Abstract] [Full Text] [Related]

  • 3. Evidence for a high-affinity uptake system for cholecystokinin octapeptide (CCK8) in rat cortical synaptosomes.
    Migaud M, Roques BP, Durieux C.
    Eur J Neurosci; 1995 May 01; 7(5):1074-9. PubMed ID: 7613612
    [Abstract] [Full Text] [Related]

  • 4. Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand.
    Van Dijk A, Richards JG, Trzeciak A, Gillessen D, Möhler H.
    J Neurosci; 1984 Apr 01; 4(4):1021-33. PubMed ID: 6325601
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
    Knapp RJ, Vaughn LK, Fang SN, Bogert CL, Yamamura MS, Hruby VJ, Yamamura HI.
    J Pharmacol Exp Ther; 1990 Dec 01; 255(3):1278-86. PubMed ID: 2262906
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of cholecystokinin receptor sites in guinea-pig cortical membranes using [125I]Bolton Hunter-cholecystokinin octapeptide.
    Lin CW, Miller T.
    J Pharmacol Exp Ther; 1985 Mar 01; 232(3):775-80. PubMed ID: 2983069
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
    Cunha RA, Johansson B, Constantino MD, Sebastião AM, Fredholm BB.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb 01; 353(3):261-71. PubMed ID: 8692280
    [Abstract] [Full Text] [Related]

  • 15. Photoaffinity labeling of central cholecystokinin receptors with high efficiency.
    Thiele C, Fahrenholz F.
    Biochemistry; 1993 Mar 23; 32(11):2741-6. PubMed ID: 8457542
    [Abstract] [Full Text] [Related]

  • 16. In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264.
    Durieux C, Ruiz-Gayo M, Roques BP.
    Eur J Pharmacol; 1991 Dec 17; 209(3):185-93. PubMed ID: 1797561
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.